Carisma Therapeutics Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Steve Kelly
Chief Executive Officer (CEO)
US$3.5m
Compensación total
| Porcentaje del salario del CEO | 13.2% |
| Permanencia del CEO | 1.7yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | 1.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Companies Like Carisma Therapeutics (NASDAQ:CARM) Could Be Quite Risky
Sep 02
US$8.40: That's What Analysts Think Carisma Therapeutics, Inc. (NASDAQ:CARM) Is Worth After Its Latest Results
May 12Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 26%
Apr 19We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate
Mar 26Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop
Jan 21The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 27%
Dec 07Analyst Forecasts Just Became More Bearish On Carisma Therapeutics, Inc. (NASDAQ:CARM)
Nov 12Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
Oct 05We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely
Jun 15Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$64m |
| Jun 30 2024 | n/a | n/a | -US$73m |
| Mar 31 2024 | n/a | n/a | -US$81m |
| Dec 31 2023 | US$4m | US$461k | -US$87m |
| Sep 30 2023 | n/a | n/a | -US$83m |
| Jun 30 2023 | n/a | n/a | -US$80m |
| Mar 31 2023 | n/a | n/a | -US$75m |
| Dec 31 2022 | US$666k | US$440k | -US$61m |
| Sep 30 2022 | n/a | n/a | -US$57m |
| Jun 30 2022 | n/a | n/a | -US$49m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$1m | US$416k | -US$41m |
Compensación vs. Mercado: La compensación total de Steve($USD3.50M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD646.00K).
Compensación vs. Ingresos: La compensación de Steve ha aumentado mientras la empresa no es rentable.
CEO
Steve Kelly (59 yo)
1.7yrs
Permanencia
US$3,504,425
Compensación
Mr. Steven Kelly, also known as Steve, is President, Chief Executive Officer and Director of Carisma Therapeutics, Inc. He served as President, Chief Executive Officer and Director of CARISMA Therapeutics...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 1.7yrs | US$3.50m | sin datos | |
| Co-Founder & Chief Scientific Officer | 1.7yrs | US$1.60m | 1.16% $ 411.7k | |
| CFO, Chief Compliance Officer | 1.7yrs | US$1.66m | 0% $ 0 | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| General Counsel & Corporate Secretary | 1.4yrs | sin datos | sin datos | |
| Senior Vice President of Human Resources | 1.4yrs | sin datos | sin datos | |
| Chief Business Officer | 4.8yrs | sin datos | sin datos | |
| Chief Medical Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Technical Operations | less than a year | sin datos | sin datos |
1.5yrs
Permanencia media
52.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CARM no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 1.7yrs | US$3.50m | sin datos | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Chairman of the Board | 1.7yrs | US$271.55k | 0.00099% $ 351.3 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 4.3yrs | sin datos | sin datos | |
| Independent Director | 1.7yrs | US$220.20k | 0.029% $ 10.3k | |
| Director | less than a year | sin datos | sin datos | |
| Independent Director | less than a year | sin datos | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 4.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 1.8yrs | sin datos | sin datos |
1.7yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de CARM no se considera experimentada (1.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.